Oxbow Advisors’s Core Laboratories CLB Stock Holding History

Oxbow Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-36,764	Closed	-$4.03M	–	227
2017 Q4	$4.03M	Buy	+36,764	New	+$3.67M	0.75%	40

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Oxbow Advisors's CLB Position: Q1 2018 in Review

Oxbow Advisors sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 36,764 shares — an estimated $4.03M sold.

Oxbow Advisors first reported a position in CLB in Q4 2017 and held it in 1 quarter. The position peaked at $4.03M in Q4 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

Oxbow Advisors reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
Oxbow Advisors sold 36,764 Core Laboratories shares in Q1 2018, an estimated $4.03M.
Oxbow Advisors first reported a position in Core Laboratories in Q4 2017 and held it in 1 quarter.
Oxbow Advisors's Core Laboratories position peaked at $4.03M in Q4 2017.
355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Oxbow Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.